What amount sold does OxyDial Inc report in Form D filings?

The latest linked filings report $700K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was OxyDial Inc's most recent SEC filing?

OxyDial Inc's most recent Form D filing was on 2026-05-20.

How many investors does OxyDial Inc have?

The most recent Form D filing lists 8 investor(s).

What type of securities does OxyDial Inc offer?

OxyDial Inc's SEC Form D filings indicate equity offerings.

OxyDial Inc

CIK: 0002126739·Other Health Care·Philadelphia, PA·Corporation·Founded 2022

Reported Sold

$700,000

Total Filings

Identified Offerings

Last Filed

May 20, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

May 20, 2026Form D — New notice

Reported sold: $700,000 · Target: $1,500,000

Rule 506(b)·8 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$700,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Filing History

Date	Type	Offering target	Reported sold	Investors
May 20, 2026	New	$1,500,000	$700,000	8

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

McAllen Digestive Surgery Center, LLC

Other Health Care

Offering target: $2,082,500

Filed Sep 30, 2026